Template:Further points for assessing the study: Difference between revisions
Appearance
No edit summary |
No edit summary |
||
| Line 12: | Line 12: | ||
|- | |- | ||
! style="text-align:left; text-indent:3em;" | - Reasons for insufficient sample size based on power analysis | ! style="text-align:left; text-indent:3em;" | - Reasons for insufficient sample size based on power analysis | ||
| style="text-align:center | | style="text-align:center;" | [[Reasons given for samples being too small according to power analysis::{{{Reasons given for samples being too small according to power analysis|}}}]] | ||
|- | |- | ||
! style="text-align:left;" | If no power analysis performed: at least moderate sample size (n >= 30 per arm) | ! style="text-align:left;" | If no power analysis performed: at least moderate sample size (n >= 30 per arm) | ||
| Line 27: | Line 27: | ||
|- | |- | ||
! style="text-align:left; text-indent:3em;" | - Possibility of attention effects | ! style="text-align:left; text-indent:3em;" | - Possibility of attention effects | ||
| [[Possibility of attention effects::{{{Possibility of attention effects|}}}]] | |||
|- | |- | ||
! style="text-align:left; text-indent:3em;" | - Possibility of placebo effects | ! style="text-align:left; text-indent:3em;" | - Possibility of placebo effects | ||
| [[Possibility of placebo effects::{{{Possibility of placebo effects|}}}]] | |||
|- | |- | ||
! style="text-align:left; text-indent:3em;" | - Other reasons | ! style="text-align:left; text-indent:3em;" | - Other reasons | ||
| [[Other reasons::{{{Other reasons|}}}]] | |||
|} | |} | ||
==Statistics== | ==Statistics== | ||
Revision as of 12:08, 28 August 2024
This is the "Further points for assessing the study" template.
It should be called in the following format:
{{Further points for assessing the study
|Samples sufficiently large=
|power analysis performed=
|reasons given for samples=
|Ethnicity mentioned=
|Possibility of attention effects=
|Possibility of placebo effects=
|Other reasons=
|Testing for normal distribution=
|Correct application of statistical=
|Correction for multiple testing=
|Measurement of compliance=
|Blinding reliable=
|Check whether blinding was successful=
|Consistent reporting in numbers=
|Sufficient washout period=
|Tested for carry-over=
|Were sequence effects tested=
|Comprehensive and coherent reporting=
|Were side effects systematically recorded=
|Effect sizes reported=
|Side effects taken into account in the interpretation of the results=
|mono- or multicentric=
|Ethics / CoI / Funding=
}}
Edit the page to see the template text.